Immunovant IMVT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 25.42 | 104.84 | -0.61 | -114,362 | -111 | |
| 2025Q3 | 16.12 | 104.65 | -0.72 | -131,762 | -127 | |
| 2025Q2 | 16.00 | 106.29 | -0.71 | -127,224 | -121 | |
| 2025Q1 | 17.09 | 107.52 | -0.63 | -113,825 | -106 | |
| 2024Q4 | 24.77 | 103.00 | -0.76 | -114,303 | -111 | |
| 2024Q3 | 28.51 | 106.15 | -0.74 | -115,743 | -109 | |
| 2024Q2 | 26.40 | 108.28 | -0.60 | -94,281 | -87 | |
| 2024Q1 | 32.31 | 107.71 | -0.52 | -80,879 | -75 | |
| 2023Q4 | 42.13 | 119.46 | -0.35 | -61,553 | -51 | |
| 2023Q3 | 38.39 | 106.17 | -0.44 | -61,800 | -59 | |
| 2023Q2 | 18.97 | 106.12 | -0.57 | -78,477 | -74 | |
| 2023Q1 | 15.51 | 106.35 | -0.45 | -64,259 | -59 | |
| 2022Q4 | 17.75 | 101.89 | -0.50 | -64,028 | -63 | |
| 2022Q3 | 5.58 | 104.08 | -0.41 | -49,614 | -48 | |
| 2022Q2 | 3.90 | 100.88 | -0.35 | -40,375 | -40 | |
| 2022Q1 | 5.51 | 100.09 | -0.41 | -47,227 | -47 | |
| 2021Q4 | 8.52 | 99.72 | -0.36 | -41,271 | -41 | |
| 2021Q3 | 8.69 | 99.77 | -0.35 | -37,649 | -38 | |
| 2021Q2 | 10.57 | 97.95 | -0.31 | -29,886 | -30 | |
| 2021Q1 | 16.04 | 102.41 | -0.28 | -28,917 | -28 |